- Home
- MDRR vs BRTX Comparison
MDRR vs BRTX Comparison
Compare MDRR & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- BRTX
- Stock Information
- Founded
- MDRR 2015
- BRTX 1997
- Country
- MDRR United States
- BRTX United States
- Employees
- MDRR N/A
- BRTX N/A
- Industry
- MDRR Real Estate Investment Trusts
- BRTX Managed Health Care
- Sector
- MDRR Real Estate
- BRTX Health Care
- Exchange
- MDRR Nasdaq
- BRTX Nasdaq
- Market Cap
- MDRR 15.6M
- BRTX 12.5M
- IPO Year
- MDRR 2018
- BRTX N/A
- Fundamental
- Price
- MDRR $11.30
- BRTX $1.41
- Analyst Decision
- MDRR
- BRTX Strong Buy
- Analyst Count
- MDRR 0
- BRTX 1
- Target Price
- MDRR N/A
- BRTX $18.00
- AVG Volume (30 Days)
- MDRR 640.0
- BRTX 106.5K
- Earning Date
- MDRR 08-12-2025
- BRTX 08-12-2025
- Dividend Yield
- MDRR 2.39%
- BRTX N/A
- EPS Growth
- MDRR N/A
- BRTX N/A
- EPS
- MDRR N/A
- BRTX N/A
- Revenue
- MDRR $9,485,128.00
- BRTX $391,000.00
- Revenue This Year
- MDRR N/A
- BRTX $216.71
- Revenue Next Year
- MDRR N/A
- BRTX $60.63
- P/E Ratio
- MDRR N/A
- BRTX N/A
- Revenue Growth
- MDRR N/A
- BRTX 161.54
- 52 Week Low
- MDRR $9.55
- BRTX $1.21
- 52 Week High
- MDRR $15.00
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- MDRR 53.75
- BRTX 34.84
- Support Level
- MDRR $10.45
- BRTX $1.42
- Resistance Level
- MDRR $11.34
- BRTX $1.67
- Average True Range (ATR)
- MDRR 0.12
- BRTX 0.11
- MACD
- MDRR 0.06
- BRTX -0.02
- Stochastic Oscillator
- MDRR 86.87
- BRTX 5.13
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.